Accuitis
Pre-clinicalOur lead compound HAS been validated in extensive preclinical research and development to restore mitochondrial sirt3 expression resulting in restoration of healthy cellular function in neurodegenerative diseases such as Alzheimer's, Parkinson's disease, and methamphetamine Addiction
Founded
2015
Focus
Small Molecules
About
Our lead compound HAS been validated in extensive preclinical research and development to restore mitochondrial sirt3 expression resulting in restoration of healthy cellular function in neurodegenerative diseases such as Alzheimer's, Parkinson's disease, and methamphetamine Addiction
Funding History
1Total raised: $2.5M
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2015
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile